Peter Hoang
2020
In 2020, Peter Hoang earned a total compensation of $1.4M as President and Chief Executive Officer at TapImmune.
Compensation breakdown
| Non-Equity Incentive Plan | $209,000 |
|---|---|
| Option Awards | $748,200 |
| Salary | $416,882 |
| Total | $1,374,082 |
Hoang received $748.2K in option awards, accounting for 54% of the total pay in 2020.
Hoang also received $209K in non-equity incentive plan and $416.9K in salary.
Rankings
In 2020, Peter Hoang's compensation ranked 7,239th out of 13,090 executives tracked by ExecPay. In other words, Hoang earned more than 44.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,239 out of 13,090 | 45th |
Division Manufacturing | 3,028 out of 5,618 | 46th |
Major group Chemicals And Allied Products | 1,221 out of 2,251 | 46th |
Industry group Drugs | 1,054 out of 1,951 | 46th |
Industry Pharmaceutical Preparations | 787 out of 1,456 | 46th |
Source: SEC filing on April 15, 2022.
Hoang's colleagues
We found two more compensation records of executives who worked with Peter Hoang at TapImmune in 2020.